Journal of Ophthalmic and Optometric Sciences

Vol. 7 No. 1 (2023)

Pathological Manifestations of the Iris in Primary Chronic Open-Angle Glaucoma Pathological Manifestations of the Iris

Journal of Ophthalmic and Optometric Sciences, Vol. 7 No. 1 (2023), 1 January 2023 , Page 18-23
https://doi.org/10.22037/joos.v7i1.45784

Abstract

Purpose: This study aims to assess the histopathological changes in the iris of patients diagnosed with primary chronic open-angle glaucoma (PCOAG) undergoing trabeculectomy surgery.
Patients and Methods: Conducted at the Imam Hossein Medical Center in Tehran, Iran, this study included 25 patients diagnosed with PCOAG scheduled for trabeculectomy. Exclusion criteria included patients with diabetes mellitus, systemic hypertension, uveitis, vascular lesions, central retinal vein occlusion, pseudoexfoliation, iris neovascularization, and previous prostaglandin usage. Following peripheral iridectomy, iris specimens were fixed in 10 % formalin, processed, and stained with hematoxylin and eosin for histopathological examination. The evaluation focused on vascular hyalinization, anterior border layer (ABL) thickness, stromal pigmentation, and pigmented epithelium characteristics.
Results: Twenty-five patients (mean age 64.4 ± 8.8 years) participated in the study. Notable findings included vascular hyalinization in 72 % of patients, ABL thickening in 48 %, severe stromal pigmentation in 40 %, and vacuolated or depigmented epithelium in 32 % and 4 % of patients, respectively. Intranuclear inclusions and nuclear invaginations were noted in 88 % of cases. The average number of glaucoma medications used per patient was 1.3 ± 1.1.Z
Conclusion: The present study results underscore the significant histopathological alterations in the iris in PCOAG patients. These changes are likely influenced by factors such as aging, patient ethnicity, and increased intraocular pressure. Gaining a deeper understanding of these changes is vital for advancing PCOAG management and treatment methodologies.

Keywords:
  • Iris
  • Chronic
  • Open-Angle
  • , Glaucoma
  • Manifestations

How to Cite

Nassiri, N., Shahriari , M., Delavari , Z. S., Porkar Rezaeyeh, A., Kavousnezhad , S., & Sheibani , K. (2023). Pathological Manifestations of the Iris in Primary Chronic Open-Angle Glaucoma: Pathological Manifestations of the Iris. Journal of Ophthalmic and Optometric Sciences, 7(1), 18–23. https://doi.org/10.22037/joos.v7i1.45784

References

Borrás T. The cellular and molecular biology of the iris, an overlooked tissue: the iris and pseudoexfoliation glaucoma. J Glaucoma. 2014;23(8 Suppl 1):S39-42.

Rask-Madsen C, King GL. Vascular complications of diabetes: mechanisms of injury and protective factors. Cell Metab. 2013;17(1):20-33.

Sun C, Ladores C, Hong J, Nguyen DQ, Chua J, Ting D, Schmetterer L, Wong TY, Cheng CY, Tan ACS. Systemic hypertension associated retinal microvascular changes can be detected with optical coherence tomography angiography. Sci Rep. 2020;10(1):9580.

Parihar JK. Glaucoma: The 'Black hole' of irreversible blindness. Med J Armed Forces India. 2016 Jan;72(1):3-4.

Greco A, Rizzo MI, De Virgilio A, Gallo A, Fusconi M, de Vincentiis M. Emerging Concepts in Glaucoma and Review of the Literature. Am J Med. 2016;129(9):1000.e7-1000.e13.

Balikov DA, Jacobson A, Prasov L. Glaucoma Syndromes: Insights into Glaucoma Genetics and Pathogenesis from Monogenic Syndromic Disorders. Genes (Basel). 2021;12(9):1403.

Khaw PT, Shah P, Elkington AR. Glaucoma--1: diagnosis. BMJ. 2004 Jan 10;328(7431):97-9. doi: 10.1136/bmj.328.7431.97. Erratum in: BMJ. 2004;328(7442):762.

Albert DM, Gangnon RE, Grossniklaus HE, Green WR, Darjatmoko S, Kulkarni AD. A study of histopathological features of latanoprost-treated irides with or without darkening compared with non-latanoprost-treated irides. Arch Ophthalmol. 2008;126(5):626-31.

Pfeiffer N, Grierson I, Goldsmith H, Hochgesand D, Winkgen-Böhres A, Appleton P. Histological effects in the iris after 3 months of latanoprost therapy: the Mainz 1 study. Arch Ophthalmol. 2001;119(2):191-6.

Grierson I, Pfeiffer N, Cracknell KP, Appleton P. Histology and fine structure of the iris and outflow system following latanoprost therapy. Surv Ophthalmol. 2002;47 Suppl 1:S176-84.

Teus MA, Arranz-Márquez E, Lucea-Suescun P. Incidence of iris colour change in latanoprost treated eyes. Br J Ophthalmol. 2002;86(10):1085-8.

Sidhartha E, Gupta P, Liao J, Tham YC, Cheung CY, He M, et al. Assessment of iris surface features and their relationship with iris thickness in Asian eyes. Ophthalmology. 2014;121(5):1007-12.

Arranz-Marquez E, Teus MA, Saornil MA, Mendez MC, Gil R. Analysis of irises with a latanoprost-induced change in iris color. Am J Ophthalmol. 2004;138(4):625-30.

  • Abstract Viewed: 76 times
  • pdf Downloaded: 133 times

Download Statastics

Current Issue